University of Arizona startup SinfoníaRx has been acquired by Tabula Rasa HealthCare, a public health care company that provides individualized, data-driven technology solutions.
SinfoníaRx is a health care company whose mission is to provide the highest-quality solutions for health plans, patients and caregivers. Spun out as a UA startup company in 2013, SinfoníaRx pioneered modern medication therapy management, or MTM, services.
The initial software and business model for SinfoníaRx was developed by Boesen and a team of health care professionals at the UA College of Pharmacy. The program's state-of-the-art software system proactively evaluates hundreds of millions of prescriptions and medical claims annually to identify opportunities to reduce the risk of adverse events and drug interactions, improve medication adherence, and look for opportunities to reduce the cost of medication treatments.
SinfoníaRx executed a strategy around hiring students and graduates of the College of Pharmacy, propelling company growth while expanding opportunities for UA students.
SinfoníaRx President Kevin Boesen, the original visionary behind the system, and CEO Fletcher McCusker co-founded SinfoníaRx with the support of Tech Launch Arizona. TLA is the commercialization arm of the UA for inventions stemming from research and innovations developed by faculty and staff.